Wednesday, October 11, 2017 12:18:19 PM
Medtronic PLC (NYSE:MDT) Technical Outlook
Leading medical device manufacturer Medtronic PLC (NYSE:MDT) has been under selling pressure since June 26th, 2017. At that time, the stock traded as high as $89.72 a share before topping out. Today, MDT stock is trading around $78.00 a share and should still have a bit more downside in the near term. Traders and investors should now watch the $74.50 level as the next major chart support area. This support level matches up nicely with the weekly 200 period moving average. It is also important to note that this area was where the stock was defended in January 2017.
Nicholas Santiago
InTheMoneyStocks
Leading medical device manufacturer Medtronic PLC (NYSE:MDT) has been under selling pressure since June 26th, 2017. At that time, the stock traded as high as $89.72 a share before topping out. Today, MDT stock is trading around $78.00 a share and should still have a bit more downside in the near term. Traders and investors should now watch the $74.50 level as the next major chart support area. This support level matches up nicely with the weekly 200 period moving average. It is also important to note that this area was where the stock was defended in January 2017.
Nicholas Santiago
InTheMoneyStocks
Recent MDT News
- Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates • GlobeNewswire Inc. • 05/12/2026 08:18:12 PM
- Orchestra BioMed Targeting BACKBEAT Trial Enrollment Completion By End of Q3 2026 and Data Presentation in Q2 2027 • GlobeNewswire Inc. • 05/12/2026 12:30:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 05/07/2026 12:11:08 AM
- Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement • GlobeNewswire Inc. • 05/06/2026 12:01:00 PM
- Orchestra BioMed Receives $20 Million Payment from Medtronic Under Previously Announced Financing Agreement • GlobeNewswire Inc. • 05/06/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/04/2026 09:12:29 PM
- FDA Grants Orchestra BioMed Additional Breakthrough Device Designation for AVIM Therapy • GlobeNewswire Inc. • 04/30/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/29/2026 08:18:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/29/2026 08:16:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/29/2026 08:15:49 PM
- Why Medtech Giants Are Quietly Paying Up for AI Diagnostics • PR Newswire (US) • 04/29/2026 02:30:00 PM
- Why Medtech Giants Are Quietly Paying Up for AI Diagnostics • PR Newswire (Canada) • 04/29/2026 02:30:00 PM
- Medtronic announces CE Mark for Stealth AXiS™ surgical system • PR Newswire (US) • 04/28/2026 08:00:00 AM
- Medtronic Discloses Cybersecurity Incident Involving IT Systems • IH Market News • 04/27/2026 03:22:46 PM
- Medtronic announces key Affera™ clinical study milestones for Sphere-9™ and Sphere-360™ catheters as global adoption continues • PR Newswire (US) • 04/25/2026 04:30:00 PM
- Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026 • GlobeNewswire Inc. • 04/23/2026 04:00:00 PM
- Medtronic completes acquisition of CathWorks, expanding its leadership in transforming care for patients with cardiovascular disease • PR Newswire (US) • 04/20/2026 11:50:00 AM
- The Infrastructure Play Hiding in Plain Sight Across Cardiac Care • GlobeNewswire Inc. • 04/16/2026 03:00:00 PM
- Medtronic to announce financial results for its fourth quarter and full fiscal year 2026 • PR Newswire (US) • 04/13/2026 10:00:00 AM
- Telix Strengthens Board with Additional Director Appointments • GlobeNewswire Inc. • 04/08/2026 10:44:20 PM
- Medtronic Receives FDA Clearance for Stealth AXiS™ Surgical System for Cranial and ENT Procedures • PR Newswire (US) • 03/27/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 08:42:04 PM
- Medtronic OmniaSecure™ defibrillation lead is the first lead of its kind to receive FDA approval for conduction system pacing • PR Newswire (US) • 03/23/2026 01:00:00 PM
- Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update • GlobeNewswire Inc. • 03/12/2026 12:17:40 PM
